ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to Gilead Sciences, November 05, 2020

ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to Gilead Sciences LEIDEN, Netherlands, Nov. 5, 2020 /PRNewswire/ — ProteoNic, a leading provider of technology and services for efficient production of biologics, today announced it has licensed its premium 2G UNic™ technology for boosting therapeutic protein production to Gilead Sciences, Inc. (Nasdaq: GILD).  Under the agreement, Gilead…